Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYRoche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual MeetingPREV STORYOPKO Health Reports 2019 First Quarter Business Highlights and Financial Results